Choong Ang Vaccine Laboratory Co. Ltd Tangible Net Worth Ratio

Latest as of June 2026: 99.1%

Choong Ang Vaccine Laboratory Co. Ltd tangible net worth ratio. Choong Ang Vaccine Laboratory Co. Ltd (072020) has a Tangible Net Worth Ratio of 99.1% as of June 2026. This metric is calculated by deducting intangible assets (₩1.01 Billion) from net assets (₩108.11 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Choong Ang Vaccine Laboratory Co. Ltd to assess the company's strategic physical and investment asset allocation.

Tangible NW Ratio

99.1%
Tangible equity / total equity

Net Assets (Equity)

₩108.11 Billion
KRW

Intangible Assets

₩1.01 Billion
Goodwill, patents, brand value

Total Assets

₩125.52 Billion
KRW

Tangible Net Worth Ratio of Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

Tangible net worth ratio of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025. This chart shows how Choong Ang Vaccine Laboratory Co. Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 99.1%, reflecting net assets of ₩108.11 Billion with intangible assets of ₩1.01 Billion KRW. See Choong Ang Vaccine Laboratory Co. Ltd (072020) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Choong Ang Vaccine Laboratory Co. Ltd Tangible Net Worth Ratio by Year (2014–2025)

Choong Ang Vaccine Laboratory Co. Ltd tangible net worth ratio by year from 2014 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Choong Ang Vaccine Laboratory Co. Ltd stock valuation.

Year Tangible NW Ratio Net Assets (KRW) Intangible Assets Total Assets Change (pp)
2025 99.0% ₩105.37 Billion ₩1.09 Billion ₩122.82 Billion ▼ 0.0 pp
2024 99.0% ₩103.87 Billion ₩1.06 Billion ₩123.28 Billion ▼ -0.5 pp
2023 99.5% ₩99.80 Billion ₩532.98 Million ₩119.59 Billion ▼ -0.1 pp
2022 99.5% ₩95.30 Billion ₩438.64 Million ₩114.86 Billion ▼ -0.1 pp
2021 99.6% ₩92.98 Billion ₩325.47 Million ₩112.95 Billion ▲ +0.2 pp
2020 99.5% ₩87.55 Billion ₩445.81 Million ₩104.98 Billion ▲ +0.4 pp
2019 99.1% ₩86.37 Billion ₩773.52 Million ₩96.57 Billion ▲ +0.3 pp
2018 98.8% ₩85.00 Billion ₩998.38 Million ₩96.74 Billion ▲ +0.3 pp
2017 98.5% ₩64.68 Billion ₩951.16 Million ₩81.62 Billion ▲ +0.3 pp
2016 98.2% ₩60.37 Billion ₩1.07 Billion ₩73.54 Billion ▲ +0.6 pp
2015 97.7% ₩54.88 Billion ₩1.29 Billion ₩62.10 Billion ▼ -1.6 pp
2014 99.2% ₩51.99 Billion ₩395.32 Million ₩60.60 Billion —
pp = percentage points